Introduction
Experimental acute inflammation can be produced by subplantar injection of a number of irritant substances in the hindpaw of rat. Among those of special interest is carrageenan, a sulphated saccharide derived from the red seaweed (Bucheuma spinosum) that induces hindpaw oedema. Carrageenan-induced oedema involves predominantly the mediation of cyclooxygenase products of acid arachidonate and this oedema is suppressed by all nonsteroidal anti-inflammatory drugs (NSAIDS). 2 Although this model system bears little relation to human disease conditions, it has significant predictive value for clinically useful anti-inflammatory agents. [3] [4] [5] However, there is controversy about the effects of these drugs on the response to carrageenan. For example, compounds of gold, the most efficacious drugs for rheumatoid arthritis, have absolutely no effect on carrageenan-induced oedema. 6 Therefore, the search for novel model systems continues in the development of new anti-inflammatory drugs.
The present paper describes the oedemagenic potential of Pilocarpus spicatus essential oil (PSEO) in the hindpaw of rat and the mediator substances involved in its action. [10] [11] [12] Therefore it is reasonable to assume that PSEOinduced hindpaw oedema in rat involves serotonin at the early phase and eicosanoids, particularly leukotrienes, at the late phase.
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